Comparison of Efficacy Between Paladai and Syringe Feeding in Stable Preterm Neonates-A Randomized Control Trial

Deepti Thandaveshwara1, Shivangi Ganeshan1, Srinivasa Murthy Doreswamy1

  • 1Department of Pediatrics, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, India.

Insights

Syringe feeding for preterm neonates showed no significant difference in milk spillage compared to paladai feeding. However, nurses reported higher satisfaction with syringe feeding methods.

Area of Science:

  • Neonatal care
  • Pediatric nutrition
  • Clinical research

Background:

  • Preterm neonates' feeding abilities vary with maturity.
  • Oral feeding methods like cup/spoon or paladai are used.
  • Milk spillage with paladai feeding is a noted issue.

Purpose of the Study:

  • To compare milk spillage between paladai and syringe feeding in neonates.
  • To evaluate feeding efficiency and safety outcomes.
  • To assess nurse satisfaction with different feeding methods.

Main Methods:

  • Randomized trial with 75 nurse-baby pairs.
  • Comparison of paladai versus syringe feeding.
  • Measurement of milk spillage, feeding time, and adverse events.

Main Results:

  • No significant difference in median milk spillover volume (paladai: 3.33 mL, syringe: 3.23 mL).
  • Similar feeding completion times and rates between groups.
  • 70% of nurses reported greater satisfaction with syringe feeding.

Conclusions:

  • Syringe feeding does not increase milk spillage compared to paladai feeding.
  • Syringe feeding offers improved nurse satisfaction.
  • Further research on syringe feeding practices in neonates is warranted.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
32
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
20
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
13
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
346
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
16
Bioavailability Study Design: Absolute Versus Relative Bioavailability01:27

Bioavailability Study Design: Absolute Versus Relative Bioavailability

Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
13